F

Fluidigm Corp
F:FLB

Watchlist Manager
Fluidigm Corp
F:FLB
Watchlist
Price: 1.89 EUR 0.53% Market Closed
Market Cap: 700.1m EUR
Have any thoughts about
Fluidigm Corp?
Write Note

Fluidigm Corp
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fluidigm Corp
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
F
Fluidigm Corp
F:FLB
Tax Provision
-$139k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Tax Provision
-$641m
CAGR 3-Years
21%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Danaher Corp
NYSE:DHR
Tax Provision
-$504m
CAGR 3-Years
26%
CAGR 5-Years
9%
CAGR 10-Years
4%
Mettler-Toledo International Inc
NYSE:MTD
Tax Provision
-$159.6m
CAGR 3-Years
4%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Agilent Technologies Inc
NYSE:A
Tax Provision
-$232m
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Tax Provision
-$87m
CAGR 3-Years
20%
CAGR 5-Years
0%
CAGR 10-Years
5%
No Stocks Found

Fluidigm Corp
Glance View

Market Cap
703.6m EUR
Industry
Life Sciences Tools & Services

Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.

FLB Intrinsic Value
0.67 EUR
Overvaluation 65%
Intrinsic Value
Price
F

See Also

What is Fluidigm Corp's Tax Provision?
Tax Provision
-139k USD

Based on the financial report for Sep 30, 2024, Fluidigm Corp's Tax Provision amounts to -139k USD.

What is Fluidigm Corp's Tax Provision growth rate?
Tax Provision CAGR 1Y
80%

Over the last year, the Tax Provision growth was 80%.

Back to Top